Duke Comprehensive Cancer Ctr.
Tamoxifen acts quickly to prevent damaged breast cells from turning cancerous
Published in FDA Law Weekly, December 16th, 2004
They are manipulating this pathway with newer and safer drugs designed to prevent breast cancer without triggering the hot flashes and other side effects of tamoxifen.
Tamoxifen is currently the front-line drug to prevent breast cancer, but millions of women do not take it because of its potential to cause hot flashes, mood swings, sleep changes, blood clots, and stroke, said Victoria Seewaldt, MD, lead author of a tamoxifen study published in the November 18, 2004, issue...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2004-12-16)
More Articles from FDA Law Weekly
- Amnesty International
Violence against women fuels spread of HIV/AIDS - Aventis
Third pandemic influenza vaccine agreement signed - Becton, Dickinson and Co.
U.S. FDA alternate site clearance helps blood glucose meter users - Berlex, Inc.
Approvable letter granted for oral contraceptive containing drospirenone - BioPort Corporation
U.S. government to procure BioThrax for nation's stockpile - Biocon Limited
Indian company launches bio-insulin - More from this issue of FDA Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
